Exelixis to Present at the Bank of America Merrill Lynch Health Care Conference on May 15, 2018
̶ Presentation to be webcast on
www.exelixis.com ̶
Exelixis, Inc. (NASDAQ: EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive
Officer, will provide an overview of the company at the Bank of America Merrill Lynch Health Care Conference taking place May 15-17
in Las Vegas, NV. The Exelixis presentation is scheduled for 10:00 AM PDT / 1:00 PM EDT on Tuesday, May 15, 2018.
To access the webcast link, log onto www.exelixis.com and proceed to the News & Events / Event Calendar page under the Investors & Media
heading. Please connect to the company’s website at least 15 minutes prior to the presentation to ensure adequate time for any
software download that may be required to listen to the webcast. A replay will also be available at the same location for 14
days.
About Exelixis
Founded in 1994, Exelixis, Inc. (NASDAQ: EXEL) is a commercially successful, oncology-focused biotechnology company that strives
to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following early
work in model genetic systems, we established a broad drug discovery and development platform that has served as the foundation for
our continued efforts to bring new cancer therapies to patients in need. We discovered our lead compounds, cabozantinib and
cobimetinib, and advanced them into clinical development before entering into partnerships with leading biopharmaceutical companies
in our efforts to bring these medicines to patients globally. We are steadfast in our commitment to prudently reinvest in our
business to maximize the potential of our pipeline. We intend to supplement our existing therapeutic assets with targeted business
development activities and internal drug discovery – all to deliver the next generation of Exelixis medicines and help patients
recover stronger and live longer. Exelixis recently earned a spot on Deloitte’s Technology Fast 500 list, a yearly award program
honoring the 500 fastest-growing companies over the past four years. For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
Exelixis and the Exelixis logo are registered U.S. trademarks.
Investors Contact:
Exelixis, Inc.
Susan Hubbard, 650-837-8194
EVP, Public Affairs and
Investor Relations
shubbard@exelixis.com
or
Media Contact:
For Exelixis, Inc.
Hal Mackins, 415-994-0040
hal@torchcommunications.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20180508006274/en/